Multiply Labs develops robotic systems for automating biologics manufacturing.
Multiply Labs has raised $75.0M in total funding. The most recent round was Series B. The last funding was announced in October 2026.
Multiply Labs's investors include Founders Fund, Lux Capital, Y Combinator, AstraZeneca, Lingotto.
Multiply Labs is headquartered in San Francisco, United States.
Multiply Labs develops robotic systems for automating biologics manufacturing.
Multiply Labs is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Multiply Labs — Funding & Investors." VCBacked, October 6, 2026, https://www.vcbacked.co/company/multiply-labs. Accessed November 15, 2026.
VCBacked. (2026). Multiply Labs — Funding & Investors. Retrieved November 15, 2026, from https://www.vcbacked.co/company/multiply-labs
{{cite web |title=Multiply Labs — Funding & Investors |url=https://www.vcbacked.co/company/multiply-labs |website=VCBacked |access-date=November 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Multiply Labs? Request a listing update